At ESCRS 2025 in Copenhagen, glaucoma specialists Dr. Obeda Kailani and Dr. Ahmed Elshinnawi share how the OMNI® Surgical System is helping surgeons take confident steps toward earlier intervention for their OAG patients.
OMNI tackles all three outflow resistance points and holds up in the real world, bringing a practical MIGS approach that builds surgeon confidence and better patient outcomes.
See how data translates into everyday success. Learn more: https://omnisurgical.com/
This information is intended solely for healthcare professionals located in the UK and EU. Patients should direct questions to their healthcare professional.
INDICATIONS FOR USE: The OMNI Surgical System is indicated for the catheterization and transluminal viscodilation of Schlemm’s canal and the cutting of trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma.
For important product information including cautions and adverse events, please refer to the full instructions for use available at omnisurgical.com/international
OMNI and the Sight Sciences logo are registered trademarks of Sight Sciences, Inc.
©2025 Sight Sciences, Inc. 10/2025 OM-3672-OUS.v1
